Edwards Lifesciences heart valve approved in Europe

Edwards Lifesciences Corp. received European approval to market its Edwards Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The valve, which is implanted through the leg in a minimally invasive procedure, is for patients with severe aortic heart valve stenosis who are not good candidates for conventional open-heart valve replacement surgery.

View Full Article in:

Orange County Business Journal (Irvine, Calif.) · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD